Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability?
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-80
SponsorLovisenberg Diakonale Hospital
About this trial
This clinical trial will investigate whether metallic lateralization in reverse shoulder arthroplasty is as stable as bony lateralization during the first two postsurgical years, measured with CT-based motion analysis (CTMA).
Eligibility criteria
Qualifiers
Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis
massive glenoid medialization
Able to read or write Norwegian
Disqualifiers
Severe osteoporosis
Osteonecrosis of the humeral head
Dementia
Poor deltoid function
Trial design
Treatments tested in this trial
- BIO-RSA
- MIO-RSA
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov